Safety and tolerability profile of new antiepileptic drug treatment in children with epilepsy

Expert Opinion on Drug Safety
Romina MoaveroPaolo Curatolo

Abstract

Treatment of pediatric epilepsy requires a careful evaluation of the safety and tolerability profile of antiepileptic drugs (AEDs) to avoid or minimize as much as possible adverse events (AEs) on various organs, hematological parameters, and growth, pubertal, motor, cognitive and behavioral development. Treatment-emergent AEs (TEAEs) reported in the literature 2000-2018 regarding second- and third-generation AEDs used in the pediatric age, with exclusion of the neonatal period that exhibits specific peculiarities, have been described on the basis of their frequency, severity/tolerability, and particular association with a given AED. Somnolence/sedation and behavioral changes, like irritability and nervousness, are among the most commonly observed TEAEs associated with almost all AEDs. Lamotrigine, Gabapentin, Oxcarbazepine, and Levetiracetam appear to be the best-tolerated AEDs with a ≤2% withdrawal rate, while Tiagabine and Everolimus are discontinued in up to >20% of the patients because of intolerable TEAEs. For some AEDs, literature data are scanty to draw a high-level evidence on their safety and tolerability profile. The reasons are: insufficient population size, short duration of treatments, or lack of controlled trials....Continue Reading

References

Dec 1, 1989·Journal of Comparative Psychology·M T Phelps, W A Roberts
Sep 29, 2000·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·T BalslevJ Buchholt
Apr 18, 2001·Clinical Neuropharmacology·M V Ragucci, J M Cohen
Aug 25, 2001·Epilepsia·J M Pellock
Oct 24, 2001·Epilepsy Research·M R CilioF Vigevano
Mar 7, 2002·Epilepsia·J M PellockW D Shields
Mar 4, 2003·Journal of Neurology, Neurosurgery, and Psychiatry·Philip E M Smith, Sheila J Wallace
Jul 18, 2003·Clinical Therapeutics·Michael J McLean, Barry E Gidal
Aug 10, 2005·Seizure : the Journal of the British Epilepsy Association·S Al AjlouniA S Daoud
Nov 24, 2005·Epilepsia·J Chaves, J W Sander
Jan 19, 2006·Journal of Child Neurology·Salvatore GrossoPaolo Balestri
Feb 28, 2006·Epilepsia·Lawrence J HirschStanley R Resor
May 2, 2006·Pediatric Neurology·Sanjeev V KothareAgustin Legido
Aug 8, 2006·Epilepsy Research·John M PellockMary L Zupanc
Oct 25, 2006·Neurology·Nathalie JetteCigdem Inan Akman
Apr 17, 2007·International Review of Neurobiology·H Steve WhiteKaren S Wilcox
Jun 19, 2007·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Gerhard KlugerHans Holthausen
Mar 18, 2008·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Shlomo ShinnarJoan A Conry
Jul 1, 2008·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Ignacio ValenciaAgustín Legido
Jul 19, 2008·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·S GrossoP Balestri
Feb 21, 2009·Epilepsia·L James WillmoreW Donald Shields
Dec 1, 2007·Journal of Clinical Neurology·Sung-Pa ParkSoon-Hak Kwon
Nov 28, 2009·Seizure : the Journal of the British Epilepsy Association·Hui Jeen TanRachel Kneen
Mar 5, 2010·Acta Neurologica Scandinavica·G KlugerS Arroyo
Mar 20, 2010·Epilepsy Research·E Ben-MenachemP Soares-da-Silva
Apr 14, 2010·Epilepsia·Aphrodite DracopoulosO Carter Snead
Apr 15, 2010·JAMA : the Journal of the American Medical Association·Elisabetta PatornoSebastian Schneeweiss
Apr 21, 2010·Journal of Child Neurology·Roy D EltermanStephen D Collins

❮ Previous
Next ❯

Citations

Dec 29, 2020·Expert Opinion on Drug Safety·Janet Mifsud de Gray
Dec 20, 2020·Expert Review of Neurotherapeutics·Krzysztof Łukawski, Stanisław J Czuczwar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.